May 2024 StemCyte CEO Tong-Young Lee PhDTong-Young Lee, PhD, is a modest man who will repeatedly tell you that he “was lucky”, when it is clear that much of his success is the result of brilliance and hard work. Tong-Young Lee grew up in Taiwan and earned a PhD in pathology from Taiwan National...Read More

Published: 2024-05-23 NEWS PROVIDED BY StemCyte May 23, 2024, 11:47 ET BALDWIN PARK, Calif., May 23, 2024 /PRNewswire/ — StemCyte, a leader in cord blood-based regenerative therapeutics in Southern California, is excited to announce the renewal of its partnership with the California State Umbilical Cord Blood Collection Program (CA-UCBCP). In collaboration with UC Davis Health,...Read More

Published: 2023-11-09 Diamond Biofund invests in full speed after its listing in Taiwian Stock Exchange. Following investing in Syncell, Diamond Biofund has announced on Nov. 8th, 2023 a significant addition of US$6.35 million investment in StemCyte to support its novel cell therapy entering into the global market and its successful capital raise of over US$25...Read More